Archives of Public Health | |
What determines inclusion in the early phase of the type 2 diabetes care trajectory in Belgium? | |
Katrien Vanthomme1  Nathalie Bossuyt1  Sarah Moreels1  Nicole Boffin1  Etienne De Clercq2  Geert Goderis3  Viviane Van Casteren1  | |
[1] Scientific Institute of Public Health, Health Services Research Unit, Brussels, Belgium | |
[2] Université Catholique de Louvain, Institut de Recherche Santé et Société (IRSS), Brussels, Belgium | |
[3] Katholieke Universiteit Leuven, Leuven, Belgium | |
关键词: Sentinel surveillance; Family practice; Chronic care; Health services research; Type 2 diabetes mellitus; | |
Others : 1070608 DOI : 10.1186/2049-3258-72-29 |
|
received in 2013-10-15, accepted in 2014-04-18, 发布年份 2014 | |
【 摘 要 】
Background
In 2009, the Belgian National Institute of Health and Disability Insurance established a care trajectory (CT) for a subgroup of type 2 diabetes mellitus patients (T2DM) based on Wagner’s chronic care model. The goal of this CT is to optimise the quality of care using an integrated multidisciplinary approach. This study aims to identify patient-related factors associated with inclusion in a CT and to determine the most frequent reasons for non-inclusion.
Methods
In 2010, the Belgian Sentinel Network of General Practices conducted a prevalence study of type 2 diabetes. The surveillance study carried out by this nationwide, representative network collected unique information about eligibility for the CT, inclusion in the CT and reasons for non-inclusion.
Based on the official inclusion and exclusion criteria, we first identified a group of eligible patients. Within this group, we then calculated the proportion of patients included in a CT as well as the prevalence of reasons for non-inclusion as reported by GPs. Furthermore, bivariate associations between patient-level parameters and inclusion were analysed. Finally, any patient-level parameters found to be statistically significant were included in a multivariate logistic regression model.
Results
The 2010 study recorded 4600 Belgian type 2 diabetes patients. According to the official criteria, 589 patients were eligible for inclusion in a CT T2DM. By the end of August 2011, 95 patients had been included in a CT T2DM.
Our findings reveal that the younger the eligible patient was, the more likely he or she was to be included in a CT. Patients living in Flanders were more likely to be included in the CT than were patients living in Wallonia. Motivated patients with specific plans to change their diets were also more likely to be included in a CT.
The two most frequently reported reasons for non-inclusion were participation in another diabetes care programme and the timing of this surveillance study (inclusion will take place in the near future).
Conclusions
Eligible diabetes patients who were admitted to a CT T2DM during the early phases of CT implementation were mainly found to be those who are able to make progress in their disease trajectories. In the future, more attention could be paid to also include more high-risk patients.
【 授权许可】
2014 Vanthomme et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20141017162929913.pdf | 191KB | download |
【 参考文献 】
- [1]Paulus D, Van den Heede K, Gerkens S, Desomer A, Mertens R: Development of a national position paper for chronic care: example of Belgium. Health Policy 2013, 111(2):105-109.
- [2]Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for patients with chronic illness. JAMA 2002, 288(15):1909-1914.
- [3]INAMI-RIZIV: Zorgtrajecten. 2013. [ http://www.zorgtraject.be/nl/index.asp webcite]
- [4]Van Casteren V, De Clercq E, Goderis G, Wens J, Moreels S, Vanthomme K, Bossuyt N: Do the national care trajectories diabetes and chronic kidney disease in Belgium improve the quality of care? Eur J Public Health 2013, 23(suppl 1):142.
- [5]Deckers JGM, Paget WJ, Schellevis FG, Fleming DM: European primary care surveillance networks: their structure and operation. Fam Pract 2006, 23(2):151-158.
- [6]Fleming DM, Schellevis FG, Van Casteren V: The prevalence of known diabetes in eight European countries. Eur J Public Health 2004, 14(1):10-14.
- [7]Lobet MP, Stroobant A, Mertens R, Van Casteren V, Walckiers D, Masuy-Stroobant G, Cornelis R: Tool for validation of the network of sentinel general practitioners in the Belgian health care system. Int J Epidemiol 1987, 16(4):612-618.
- [8]Boffin N, Bossuyt N, Van Casteren V: Kenmerken van de peilartsen en hun praktijk. Brussel: Situatie in 2010 en vergelijking met voorgaande jaren; 2011.
- [9]Van Casteren V, Bossuyt N, Moreels S, Vanthomme K, Goderis G, De Clercq E: De zorgtrajecten diabetes mellitus type 2 en chronische nierinsufficiëntie: impact op de kwaliteit van zorg. Brussel: Wetenschappelijk Instituut Volksgezondheid (WIV-ISP). 2013. Intern referentienummer 2013-018. Depotnummer of ISSN; 2013. D/2013/2505/24
- [10]Schäfer I, Küver C, Gedrose B, von Leitner E-C, Treszl A, Wegscheider K, van den Bussche H, Kaduszkiewicz H: Selection effects may account for better outcomes of the German disease management program for type 2 diabetes. BMC Health Serv Res 2010, 10(1):351. BioMed Central Full Text
- [11]Boffin N: Surveillance studies of suicidal behavior and depression by the Belgian network of sentinel general practices. Thesis submitted in fulfilment of the requirements for the degree of Doctor in Health Sciences. Ghent University, Health Sciences Department: PhD thesis; 2013.